News | January 17, 2024
Agilent announces new ProteoAnalyzer system
Automated parallel capillary electrophoresis system simplifies protein analysis
Automated parallel capillary electrophoresis system simplifies protein analysis
Bayer has granted the non-exclusive rights to Sun Pharma to market and distribute a second brand of Finerenone under the brand name Lyvelsa
Microdosing has emerged as a key trend in the pharmaceutical and nutritional markets
PharmaLogic will assist ARTBIO with radiochemistry and supply of the finished radiopharmaceutical product for future Phase I and II clinical trials of AB001 from their facility in New York
The workshop was conducted as a part of the NITI–State workshop series
The R&D centre is mainly dedicated to the Process R&D of New Chemical Entities (NCE) development projects
HIFU is a state-of-the-art treatment that utilizes high-frequency sound waves to target and destroy prostate cancer cells
Submission based on positive results from global phase 3 study demonstrating overall survival benefit of TIVDAK over chemotherapy
Acquisition expands GSK’s respiratory pipeline adding AIO-001, a phase II-ready, long-acting antibody targeting the clinically validated TSLP pathway
This investment will be made by Caplin Point Laboratories Limited and its subsidiaries - Caplin Steriles Limited and Caplin One Labs Limited
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
